Literature DB >> 16393977

Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8.

Eliana Ribechini1, Cinzia Fortini, Mauro Marastoni, Serena Traniello, Susanna Spisani, Paolo Monini, Riccardo Gavioli.   

Abstract

The human herpesvirus 8 (HHV-8) is a gamma herpesvirus with oncogenic potential which establishes a chronic infection that is normally controlled by the immune system of healthy individuals. In particular, CTL responses seem to play a key role in control of the infection. In this study, we characterized epitope-specific CTL responses in healthy HHV-8-seropositive individuals against four HHV-8 lytic Ags: open reading frames (ORF) 26, 70, K3, and K5. We found that the majority of subjects responded to at least one HHV-8 lytic Ag-derived epitope, and some of these epitopes represented dominant targets, suggesting that they could be relevant targets of CTL-mediated immunity in vivo, and may be involved in host control of HHV-8. Specifically, we identified three CTL epitopes from ORF 26, which are presented by HLA-A2, six CTL epitopes from ORF 70 presented by HLA-A2 (three epitopes), -A24 (two epitopes), and -B7 (one epitope), three CTL epitopes from ORF K3 presented by HLA-A2 (two epitopes) and -B7 (one epitope), and one HLA-A2 presented epitope derived from ORF K5. The identified epitopes may be regarded as useful tools for understanding the role of CTL responses to lytic Ags in individuals affected by HHV-8-associated disorders, and for the development of immunotherapies for the treatment/prevention of HHV-8-associated malignancies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16393977     DOI: 10.4049/jimmunol.176.2.923

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

2.  Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes.

Authors:  Florian Bihl; Murli Narayan; John V Chisholm; Leah M Henry; Todd J Suscovich; Elizabeth E Brown; Tania M Welzel; Daniel E Kaufmann; Tauheed M Zaman; Sheila Dollard; Jeff N Martin; Fred Wang; David T Scadden; Kenneth M Kaye; Christian Brander
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

3.  Monofunctional and polyfunctional CD8+ T cell responses to human herpesvirus 8 lytic and latency proteins.

Authors:  Lauren Lepone; Giovanna Rappocciolo; Emilee Knowlton; Mariel Jais; Paolo Piazza; Frank J Jenkins; Charles R Rinaldo
Journal:  Clin Vaccine Immunol       Date:  2010-08-18

Review 4.  Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus.

Authors:  Angela Nalwoga; Denise Whitby
Journal:  Curr Opin Immunol       Date:  2022-07-08       Impact factor: 7.268

5.  Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells.

Authors:  Nick C Matthews; Martin R Goodier; Rebecca C Robey; Mark Bower; Frances M Gotch
Journal:  Eur J Immunol       Date:  2011-05-27       Impact factor: 5.532

6.  The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Rebecca C Robey; Salvinia Mletzko; Frances M Gotch
Journal:  Adv Virol       Date:  2011-01-16

7.  The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens.

Authors:  Rebecca C Robey; Dimitrios Lagos; Fiona Gratrix; Stephen Henderson; Nick C Matthews; Richard J Vart; Mark Bower; Chris Boshoff; Frances M Gotch
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.